Role of Interleukin-1&bgr; in Acute Inflammation and Graft Death After Cell Transplantation to the Heart

Role of Interleukin-1&bgr; in Acute Inflammation and Graft Death After Cell Transplantation to the Heart
复制标题

IL-1 的作用

DOI:
--
复制
发表时间:
2004
期刊:
影响因子:
37.8
通讯作者:
M. Yacoub
M. Yacoub
中科院分区:
医学1区
文献类型:
--
作者:
Ken Suzuki;B. Murtuza;J. Beauchamp;N. Brand;P. Barton;A. Varela‐Carver;S. Fukushima;S. Coppen;T. Partridge;M. Yacoub

文献摘要

参考文献

被引文献

相似文献

移植细胞存活率低是阻碍细胞移植治疗效果的主要因素;然而,细胞死亡的原因仍不清楚。我们假设白细胞介素-1;(IL-1&bgr;)可能在细胞移植后的急性炎症反应和移植物死亡中起作用,抑制IL-1&bgr;可能会提高移植物的存活率。方法与结果:采用直接肌内注射的方法,将14c标记的雄性骨骼肌前体细胞植入雌性小鼠心脏。14c标记的数量提供了存活细胞数量的估计,而聚合酶链反应测量的男性特异性Smcy基因的数量表示供体来源细胞的总数(存活+增殖)。移植后10分钟,移植细胞存活率为44.8±2.4%,24小时后稳定下降至14.6±1.1%,72小时后下降至7.9±0.6%(每个点n=6)。存活细胞在24 h后开始增殖,细胞总数从24 h时的15.5±0.8%增加到72 h时的24.4±1.6%。急性炎症在24小时突出,72小时减轻,与IL-1&bgr;表达式。抗il -1&bgr;抗体可提高24(25.6±1.6%)和72小时(14.8±1.1%)的移植物存活率,使72小时总细胞数增加2倍(45.8±2.4%)。IL-1&bgr的作用;抑制作用与炎症反应的减少相对应。Conclusion-IL-1&bgr;参与直接心肌细胞移植后的急性炎症和移植物死亡。靶向抑制IL-1&bgr;可能是提高移植物存活率的有效策略。
Background—Poor survival of grafted cells is a major factor hindering the therapeutic effect of cell transplantation; however, the causes of cell death remain unclear. We hypothesized that interleukin-1&bgr; (IL-1&bgr;) might play a role in the acute inflammatory response and graft death after cell transplantation and that inhibition of IL-1&bgr; might improve graft survival. Methods and Results—14C-labeled male skeletal muscle precursor cells were implanted into female mouse hearts by direct intramuscular injection. The amount of 14C-label provides an estimate of the surviving cell number, whereas the amount of male-specific Smcy gene measured by polymerase chain reaction indicates the total (surviving+proliferated) number of donor-derived cells. At 10 minutes after implantation, 44.8±2.4% of the grafted cells survived and this steadily decreased to 14.6±1.1% by 24 hours, and to 7.9±0.6% by 72 hours (n=6 in each point). Proliferation of the surviving cells, which began after 24 hours, resulted in an increase in the total cell number from 15.5±0.8% at 24 hours to 24.4±1.6% at 72 hours. Acute inflammation was prominent at 24 hours and was reduced by 72 hours, in parallel with IL-1&bgr; expression. Administration of anti–IL-1&bgr; antibody improved graft survival at both 24 (25.6±1.6%) and 72 hours (14.8±1.1%) and resulted in a 2-fold increase in the total cell number at 72 hours (45.8±2.4%). The effects of IL-1&bgr; inhibition corresponded with a reduced inflammatory response. Conclusion—IL-1&bgr; is involved in acute inflammation and graft death after direct intramyocardial cell transplantation. Targeted inhibition of IL-1&bgr; may be a useful strategy to improve graft survival.
DOI: 10.1161/01.res.84.1.21
发表时间: 1999-01
影响因子: 20.1
作者:
Douglas J. Ing;Jie Zang;Victor J. Dzau;Keith A. Webster;N. Bishopric
通讯作者: Douglas J. Ing;Jie Zang;Victor J. Dzau;Keith A. Webster;N. Bishopric
DOI: 10.1161/01.cir.100.2.193
发表时间: 1999-07-13
期刊: CIRCULATION
影响因子: 37.8
作者:
Reinecke, H;Zhang, M;Murry, CE
通讯作者: Murry, CE
DOI: 10.1006/jmcc.1998.0829
发表时间: 1998-12-01
影响因子: 5
作者:
Frangogiannis, NG;Youker, KA;Entman, ML
通讯作者: Entman, ML
DOI: 10.1172/jci119070
发表时间: 1996-12-01
影响因子: 15.9
作者:
Murry, CE;Wiseman, RW;Hauschka, SD
通讯作者: Hauschka, SD